Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells (Q39136561)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 June 2013
edit
Language Label Description Also known as
English
Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells
scientific article published on 18 June 2013

    Statements

    Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells (English)
    Seiichiro Komatsu
    Shota Moriya
    Xiao-Fang Che
    Tomohisa Yokoyama
    Norio Kohno
    Keisuke Miyazawa
    18 June 2013
    41-47

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit